| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
The primary molecular target of Mebeverine metabolite O-desmethyl Mebeverine alcohol is the α1-adrenergic receptor. It acts as an inhibitor of α1 receptors, leading to relaxation of gastrointestinal smooth muscle. This contributes to the antispasmodic effects of mebeverine. The metabolite may also have local anesthetic properties.
|
|---|---|
| ln Vitro |
In vitro, Mebeverine metabolite O-desmethyl Mebeverine alcohol inhibits α1-adrenergic receptors in cell-based assays. It is used to study α1 receptor signaling and the pharmacology of antispasmodic agents. The compound's effects on smooth muscle relaxation are characterized in isolated tissue preparations.
|
| ln Vivo |
In vivo, Mebeverine metabolite O-desmethyl Mebeverine alcohol contributes to the antispasmodic effects of mebeverine. It causes relaxation of the gastrointestinal tract. It is used as a reference standard in pharmacokinetic studies of mebeverine. Further studies are needed to fully characterize its in vivo pharmacology.
|
| Enzyme Assay |
For in vitro α1-adrenergic receptor binding assays, membrane preparations from cells expressing α1-adrenoceptors are incubated with a radiolabeled α1-adrenoceptor ligand (e.g., [3H]-prazosin) and varying concentrations of Mebeverine metabolite O-desmethyl Mebeverine alcohol. The assay is performed in an appropriate buffer at 25°C. Bound radioactivity is separated by filtration and quantified.
|
| Cell Assay |
In vitro cell experiments for Mebeverine metabolite O-desmethyl Mebeverine alcohol employ cells expressing α1-adrenoceptors or gastrointestinal smooth muscle cells. Cells are treated with the metabolite at concentrations ranging from 0.1 to 100 μM. After 24-48 hours, endpoints such as α1-adrenoceptor signaling (calcium flux), cell viability, and smooth muscle relaxation are assessed.
|
| Animal Protocol |
In vivo animal protocols for Mebeverine metabolite O-desmethyl Mebeverine alcohol use rat or guinea pig models. The compound is administered by intraperitoneal or oral routes at doses ranging from 1 to 50 mg/kg. Gastrointestinal motility and antispasmodic effects are assessed.
|
| Molecular Formula |
C??H??NO?
|
|---|---|
| Molecular Weight |
251.3645
|
| Exact Mass |
251.189
|
| CAS # |
155172-67-1
|
| Related CAS # |
O-Desmethyl Mebeverine alcohol hydrochloride;856620-39-8;Mebeverine-d6 hydrochloride;1329647-20-2
|
| PubChem CID |
127907
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.041g/cm3
|
| Boiling Point |
400.1ºC at 760mmHg
|
| Flash Point |
191.7ºC
|
| Vapour Pressure |
4.04E-07mmHg at 25°C
|
| Index of Refraction |
1.536
|
| LogP |
2.417
|
| tPSA |
43.7
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
8
|
| Heavy Atom Count |
18
|
| Complexity |
203
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
OC1=CC=C(CC(C)N(CC)CCCCO)C=C1
|
| InChi Key |
RNGYIAYXMHMWTO-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C15H25NO2/c1-3-16(10-4-5-11-17)13(2)12-14-6-8-15(18)9-7-14/h6-9,13,17-18H,3-5,10-12H2,1-2H3
|
| Chemical Name |
4-[2-[ethyl(4-hydroxybutyl)amino]propyl]phenol
|
| Synonyms |
Mebeverine metabolite Odesmethyl Mebeverine alcohol; Mebeverine metabolite O desmethyl Mebeverine alcohol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.9784 mL | 19.8918 mL | 39.7836 mL | |
| 5 mM | 0.7957 mL | 3.9784 mL | 7.9567 mL | |
| 10 mM | 0.3978 mL | 1.9892 mL | 3.9784 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.